ACG Acquisition (LON:ACG – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Berenberg Bank in a note issued to investors on Tuesday, Digital Look reports. They presently have a GBX 2,300 target price on the stock. Berenberg Bank‘s price target would indicate a potential upside of 38.22% from the company’s current price.
Separately, Canaccord Genuity Group decreased their price target on ACG Acquisition from GBX 2,370 to GBX 2,295 and set a “buy” rating for the company in a report on Thursday, September 17th. Three research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of GBX 2,315.
View Our Latest Stock Report on ACG Acquisition
ACG Acquisition Trading Up 17.2%
ACG Acquisition stock opened at GBX 1,663.96 on Tuesday. The stock has a market cap of £385.12 million and a P/E ratio of -3.67. The company has a fifty day simple moving average of GBX 1,926.60 and a 200-day simple moving average of GBX 1,715.38. ACG Acquisition has a 12-month low of GBX 1,000 and a 12-month high of GBX 2,102.93.
ACG Acquisition (LON:ACG – Get Free Report) last issued its earnings results on Thursday, September 17th. The company reported GBX (1.70) EPS for the quarter. ACG Acquisition had a negative return on equity of 381.58% and a negative net margin of 68.97%.
ACG Acquisition Company Profile
ACG Metals is a company with a vision to build a global, high-margin, copper-focused producer with safe, efficient, and sustainable operations.
In September 2024, ACG successfully completed the acquisition of the Gediktepe Mine which is expected to transition to primary copper and zinc production from 2026 and will target annual steady-state copper equivalent production of 20-25 kt. Gediktepe produced 39.2koz of AuEq in 2025.
ACG’s team has extensive M&A experience built through decades spent at blue-chip multinationals in the sector.
See Also
- Five stocks we like better than ACG Acquisition
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for ACG Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACG Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
